TCA
SEM

Transcend Capital Advisors’s Select Medical SEM Stock Holding History

Transcend Capital Advisors’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,405
Closed -$268K – 514
2021
Q3 		$268K Buy
+15,405
New +$306K 0.02% 398

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Transcend Capital Advisors's SEM Position: Q4 2021 in Review

Transcend Capital Advisors sold out of Select Medical (SEM) in Q4 2021, closing a stake of 15,405 shares — an estimated $268K sold.

Transcend Capital Advisors first reported a position in SEM in Q3 2021 and held it in 1 quarter. The position peaked at $268K in Q3 2021. 244 funds tracked by Wall St. Rank hold SEM as of Q4 2021.

  • Transcend Capital Advisors reported no remaining Select Medical position as of Q4 2021 after selling out during the quarter.
  • Transcend Capital Advisors sold 15,405 Select Medical shares in Q4 2021, an estimated $268K.
  • Transcend Capital Advisors first reported a position in Select Medical in Q3 2021 and held it in 1 quarter.
  • Transcend Capital Advisors's Select Medical position peaked at $268K in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Select Medical as of Q4 2021.

Based on Transcend Capital Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.